Quarterly report pursuant to Section 13 or 15(d)

Borrowings (Details)

v3.21.1
Borrowings (Details) - USD ($)
3 Months Ended
Nov. 09, 2020
May 18, 2020
Mar. 09, 2020
Jan. 23, 2020
Mar. 31, 2021
Feb. 06, 2020
Apr. 18, 2019
Issuance of common stock and warrants, net of offering costs (in shares) 236,375 60,250          
Warrant exercisable for shares of common stock           4,553 12,756
Exercise price of warrants $ 2.55            
Funding Agreement | Convertible debt              
Principal amount of debt       $ 111,100      
Original issue discount       10.00%      
Issuance of common stock and warrants, net of offering costs (in shares)       500      
Term of warrant exercisable       5 years      
Warrant exercisable for shares of common stock       7,936      
Exercise price of warrants       $ 9.80      
Consideration       $ 100,000      
Period of execution of funding agreement     45 days        
Interest expense from amortization of debt discounts         $ 20,000